Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.
Friday 26 September 2014
Maximising Treatment Benefit for Patients with ALK+NSCLC
Friday, 14:00-15:30
View the satellite invitation
Hot Topics in Oncology: Biosimilar Monoclonal Antibodies
Friday, 14:00–16:00
View the satellite invitation
Painting the Global Masterpiece: Are we Close to Optimal Sequencing in HER+ Metastatic Breast Cancer?
Friday, 14:00-16:00
View the satellite invitation
Biomarkers in Colorectal Cancer and the Quest for Personalized Treatments
Friday, 14:00-16:30
View the satellite invitation
Treatment and Management Strategies for Advanced Breast Cancer Patients: Consultation With the Experts / Biomarkers in Clinical Decision-Making: Targeted Molecular Therapy in Advanced NSCLC
Friday, 14:00-18:00
View the satellite invitation
Delivering Chemotherapy with Confidence: New Strategies to Minimize Treatment Induced Nausea and Vomiting
Friday, 15:00–17:00
View the satellite invitation
Translational Advances in ER+/HER2-Breast Cancer
Friday 15:00-17:00
View the satellite invitation
Tailoring Treatment for Your Patients with mRCC: the experts answer your questions
Friday 17:00-19:00
View the satellite invitation
Improving Outcomes in mCRC and GIST by Targeting Multiple Pathways
Friday, 17:00-19:00
View the satellite invitation
Current Evidence for the Treatment of NET and GIST: Experts Clinical Insights / Second-Line Treatment of mRCC: A “Virtual Tumor Board”
Friday 17:00-20:00
View the satellite invitation
Maximising Patient Outcomes in Advanced NSCLC: Expanding the Discussion
Friday 17:40-19:45
View the satellite invitation
Immuno-Oncology: A Potential New Approach in Genitourinary Cancers
Friday 18:00-20:00
View the satellite invitation
Raising the Bar in Breast Cancer Care: Answering Clinically Relevant Questions
Friday 18:00-20:00
View the satellite invitation
Beyond Symptom Control: Continued Advances in Targeting Gastroenteropancreatic Neuroendocrine Tumors
Friday 18:00-20:00
View the satellite invitation
Saturday 27 September 2014
Designing the Future Treatment Paradigm of mCRPC
Saturday, 18:00–19:30
View the satellite invitation
Should Immuno-Oncology be the Foundational Treatment Strategy for all Patients with Melanoma?
Saturday, 18:00-20:00
View the satellite invitation
The Mutation, the Receptor and its Family: Targeting NSCLC on the Right Level
Saturday, 18:00-20:00
View the satellite invitation
Sunday 28 September 2014
Understanding the Multidisciplinary Focus for Improving Gastric Cancer Care
Sunday, 18:00-19:35
View the satellite invitation
Shaping the Future of Personalized Therapy in Ovarian Cancer: A Focus on BRCA Biomarkers
Sunday, 18:00-19:45
View the satellite invitation
Optimizing Treatment Benefits with MKIs: Understanding Who and When to Treat
Sunday, 18:00-20:00
View the satellite invitation
Efficacy, Tolerability and Quality of Life – Can these all be Achieved for Patients with mRCC?
Sunday, 18:00-20:00
View the satellite invitation
Targeting Angiogenesis in NSCLC: Science, Insight and Understanding
Sunday, 18:00-20:00
View the satellite invitation
Unlocking the Potential of Immuno-Oncology in Lung Cancer: a Multidisciplinary Perspective
Sunday, 18:00-20:00
View the satellite invitation
Monday 29 September 2014
Evolving Treatment Paradigms for Advanced NSCLC: Targeted Agents and Immunotherapeutics
Monday, 18:00-20:00
View the satellite invitation
Long-Term Patient Outcomes with BRAF Inhibitors in Metastatic Melanoma: Evidence and Experience
Monday, 18:00-19:30
View the satellite invitation
Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.
View the Complete ESMO 2014 Industry Satellite Symposia Programme